Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib Long Term vs Short Term in Knee Osteoarthritis
NCT00137410Phase 3Completed
- Sponsor
- Pfizer
- Start
- Nov 2002
- Primary completion
- Mar 2006
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of celecoxib in osteoarthritis (OA), sponsored by Pfizer. Started Nov 2002; status: completed.
02
Drugs
celecoxib
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT00137410.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00137410.